Italia markets close in 1 hour 37 minutes

ILMN Jan 2025 65.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,60000,0000 (0,00%)
In data: 09:41AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,6000
Aperto1,6000
Denaro1,6500
Domanda4,5000
Prezzo d'esercizio65,00
Scadenza2025-01-17
Min-Max giorno1,6000 - 1,6000
Contratto - Min-MaxN/D
Volume1
Open Interest146
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera